Drug name - Ximino

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8268804 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7790705 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US8252776 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7919483 JOURNEY Method for the treatment of acne Mar, 2027

(4 years from now)

US7541347 JOURNEY Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

US7544373 JOURNEY Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 45MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 67.5MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued
EQ 90MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 112.5MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued
EQ 135MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.